Can a high morning cortisol-to-DHEA-S ratio reduce immune tolerance and promote autoimmune trajectories?

The relationship between the adrenal hormones cortisol and DHEA-S is a primary driver of immune homeostasis. While cortisol is often viewed strictly as an anti-inflammatory agent, its biological impact is contingent upon the presence of DHEA-S, which acts as its functional antagonist. An elevated cortisol-to-DHEA-S ratio (CDR) creates a hormonal environment that favors systemic inflammation and the erosion of immune tolerance.

Mechanistic pathways of immune dysregulation

The shift toward reduced immune tolerance is driven by specific alterations in cellular signaling and T-cell polarization:

• T-cell balance: DHEA-S normally supports the stability and function of regulatory T-cells (Tregs), which are essential for maintaining self-tolerance. High cortisol levels, particularly when DHEA-S is low, promote the differentiation of pro-inflammatory Th17 cells. This high Th17/low Treg ratio is a hallmark of immune dysregulation.
• Inflammatory signaling: While acute cortisol suppresses inflammation, chronic elevation can lead to glucocorticoid resistance. In this state, the suppression of NF-κB is diminished, leading to the increased production of pro-inflammatory cytokines such as IL-6, TNF-α, and IL-1β.
• Molecular antagonism: DHEA-S inhibits the activation of NF-κB in mononuclear cells. A deficiency in DHEA-S removes this inhibitory layer, amplifying the inflammatory milieu initiated by HPA axis dysfunction.

Relevance to autoimmune trajectories

This hormonal imbalance serves as a "permissive" state for the development and progression of autoimmune pathologies:

• Disease progression: A high CDR is frequently observed during the preclinical stages and active flares of conditions like Systemic Lupus Erythematosus (SLE), Rheumatoid Arthritis (RA), and Hashimoto’s thyroiditis.
• Loss of B-cell tolerance: The failure of dysregulated cortisol to suppress inflammatory cytokines can compromise B-cell tolerance, leading to the expansion of autoreactive lymphocytes and the production of autoantibodies.
• Clinical correlation: Longitudinal studies indicate that individuals with prolonged HPA axis dysregulation and low DHEA-S levels have higher disease activity scores and a significantly increased risk of transitioning from subclinical inflammation to overt autoimmune disease.

Bottom line

A pattern of high morning cortisol and low DHEA-S reduces immune tolerance by favoring Th17-mediated inflammation over Treg-mediated regulation. This hormonal profile increases pro-inflammatory signaling through NF-κB and is strongly associated with the progression of autoimmune trajectories.